MiR-30a-5p inhibits proliferation and metastasis of hydatidiform mole by regulating B3GNT5 through ERK/AKT pathways

Area of Science:

• Gynecology
• Molecular Biology
• Oncology

Background:

• Hydatidiform moles are gestational trophoblastic diseases with cancerous potential.
• MicroRNA-30a (miR-30a) is a tumor suppressor implicated in various diseases.
• The specific role and mechanism of miR-30a in hydatidiform moles remain largely unknown.

Purpose of the Study:

• To investigate the expression levels of miR-30a and B3GNT5 in hydatidiform moles.
• To elucidate the functional role of miR-30a in trophoblast cell lines.
• To explore the underlying molecular mechanisms of miR-30a's action in hydatidiform mole development.

Main Methods:

• Quantitative analysis of miR-30a and B3GNT5 expression in normal placenta and hydatidiform mole tissues.
• In vitro experiments using trophoblast cell lines (JAR and BeWo) to assess cell proliferation, invasion, and migration.
• Dual-luciferase reporter assays to confirm direct targeting of B3GNT5 by miR-30a.
• Western blot analysis to examine the impact on ERK and AKT signaling pathways.

Main Results:

• Differential expression of miR-30a and B3GNT5 was observed between normal placenta and hydatidiform mole tissues.
• miR-30a significantly inhibited proliferation, invasion, and migration in trophoblast cell lines.
• miR-30a was confirmed to directly target the 3' untranslated region of B3GNT5.
• Regulation of B3GNT5 by miR-30a led to the inactivation of ERK and AKT signaling pathways.

Conclusions:

• miR-30a acts as a tumor suppressor in hydatidiform moles by directly targeting B3GNT5.
• The miR-30a/B3GNT5 axis plays a crucial role in the development of hydatidiform moles.
• miR-30a holds potential as a novel biomarker and therapeutic target for hydatidiform moles.